FindTrial
Sign In

The Role of CacyBP/ SIP in Autophagic Degradation of a Synuclein and the Pathogenesis of PD

The Role of CacyBP/ SIP in Autophagic Degradation of a Synuclein and the Pathogenesis of Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CPC-17011711
Enrollment
Unknown
Registered
2017-06-20
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Parkinson's disease group:no
healthy control group:no

Sponsors

Affiliated Lianyungang Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Sporadic Parkinson's disease that meets MDS Clinical Diagnostic Criteria(2015) of our hospital; 2. Aged 18 to 80 years old male or female; 3. Chinese Han people; 4. H&Y stages are 1-5; 5. Available for written informed consent.

Exclusion criteria

Exclusion criteria: 1. Parkinsonism or Parkinsonism-plus; 2. Cognitive impairment(scored lower than 24) or unable to cooperate with scales; 3. Exclusion criteria: Other severe accompanied diseases; 4. Pregnant woman; 5. Non-Han nationality; 6. With a family history of Parkinson's disease; 7. Unwilling to participate in the study or unavailable for written informed consent.

Design outcomes

Primary

MeasureTime frame
CacyBP;LC3;a-Synuclein;—

Countries

China

Contacts

Public ContactZenglin Cai

Affiliated Lianyungang Hospital of Xuzhou Medical University

caizengling@163.com+86 18961322001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026